# Alzamend Neuro, Inc.: Form 8-K, filed Sep 25, 2025

- Company: [Alzamend Neuro, Inc.](/companies/alzn.md) (CIK 1677077)
- Form: 8-K
- Filed: 2025-09-25
- Accepted by EDGAR: Sep 25, 2025, 16:30 ET
- Period: 2025-09-25
- Accession: 0001214659-25-014200
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/w9252538k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1677077/000121465925014200/w9252538k.htm

Filed Sep 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001214659-25-014200. Last ingested by Listed: Nov 11, 2026, 01:45 ET. No prices; not investment advice.
